Eprotirome - paediatric investigation plan

Eprotirome
PIPHuman

Key facts

Active substance
Eprotirome
Therapeutic area
Endocrinology-Gynaecology-Fertility-Metabolism
Decision number
P/128/2008
PIP number
Eprotirome
Pharmaceutical form(s)
Gastro-resistant tablet
Condition(s) / indication(s)
Primary hypercholesterolaemia
Route(s) of administration
Oral use
Contact for public enquiries

KaroBio AB

E-mail: jens.kristensen@karobio.com
Country: Sweden
Phone: +46 707556005
Fax: +46 87745280

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date
Compliance check done
No

Decision

Share this page